Persistent polypharmacy and fall injury risk: the Health, Aging and Body Composition Study

Background Older adults receive treatment for fall injuries in both inpatient and outpatient settings. The effect of persistent polypharmacy (i.e. using multiple medications over a long period) on fall injuries is understudied, particularly for outpatient injuries. We examined the association betwee...

Full description

Saved in:
Bibliographic Details
Published inBMC geriatrics Vol. 21; no. 1; pp. 710 - 10
Main Authors Xue, Lingshu, Boudreau, Robert M., Donohue, Julie M., Zgibor, Janice C., Marcum, Zachary A., Costacou, Tina, Newman, Anne B., Waters, Teresa M., Strotmeyer, Elsa S.
Format Journal Article
LanguageEnglish
Published London BioMed Central 15.12.2021
BioMed Central Ltd
BMC
Subjects
Accidental Falls
Aged
Aging
Antidepressants
Benzodiazepines
Body Composition
Chronic illnesses
Codes
Demography
Drugs
Falls
Falls (Accidents)
Female
FRID
Geriatrics
Geriatrics/Gerontology
Humans
Injuries
Injury prevention
Male
Medical records
Medicare
Medication
Medicine
Medicine & Public Health
Narcotics
Older people
Persistent polypharmacy
Physiological aspects
Polypharmacy
Prescribing
Psychotropic drugs
Rehabilitation
Risk Factors
Sensitivity analysis
Treated fall injury
United States - epidemiology
United States
United States > US
Pittsburgh Pennsylvania
Falls
Persistent polypharmacy
Medicare
FRID
Treated fall injury
Medication
Geriatrics
Online AccessGet full text
ISSN1471-2318
1471-2318
DOI10.1186/s12877-021-02695-9

Cover

Abstract Background Older adults receive treatment for fall injuries in both inpatient and outpatient settings. The effect of persistent polypharmacy (i.e. using multiple medications over a long period) on fall injuries is understudied, particularly for outpatient injuries. We examined the association between persistent polypharmacy and treated fall injury risk from inpatient and outpatient settings in community-dwelling older adults. Methods The Health, Aging and Body Composition Study included 1764 community-dwelling adults (age 73.6 ± 2.9 years; 52% women; 38% black) with Medicare Fee-For-Service (FFS) claims at or within 6 months after 1998/99 clinic visit. Incident fall injuries ( N  = 545 in 4.6 ± 2.9 years) were defined as the initial claim with an ICD-9 fall E-code and non-fracture injury, or fracture code with/without a fall code from 1998/99 clinic visit to 12/31/08. Those without fall injury ( N  = 1219) were followed for 8.1 ± 2.6 years. Stepwise Cox models of fall injury risk with a time-varying variable for persistent polypharmacy (defined as ≥6 prescription medications at the two most recent consecutive clinic visits) were adjusted for demographics, lifestyle characteristics, chronic conditions, and functional ability. Sensitivity analyses explored if persistent polypharmacy both with and without fall risk increasing drugs (FRID) use were similarly associated with fall injury risk. Results Among 1764 participants, 636 (36%) had persistent polypharmacy over the follow-up period, and 1128 (64%) did not. Fall injury incidence was 38 per 1000 person-years. Persistent polypharmacy increased fall injury risk (hazard ratio [HR]: 1.31 [1.06, 1.63]) after adjusting for covariates. Persistent polypharmacy with FRID use was associated with a 48% increase in fall injury risk (95%CI: 1.10, 2.00) vs. those who had non-persistent polypharmacy without FRID use. Risks for persistent polypharmacy without FRID use (HR: 1.22 [0.93, 1.60]) and non-persistent polypharmacy with FRID use (HR: 1.08 [0.77, 1.51]) did not significantly increase compared to non-persistent polypharmacy without FRID use. Conclusions Persistent polypharmacy, particularly combined with FRID use, was associated with increased risk for treated fall injuries from inpatient and outpatient settings. Clinicians may need to consider medication management for FRID and other fall prevention strategies in community-dwelling older adults with persistent polypharmacy to reduce fall injury risk.
AbstractList Background Older adults receive treatment for fall injuries in both inpatient and outpatient settings. The effect of persistent polypharmacy (i.e. using multiple medications over a long period) on fall injuries is understudied, particularly for outpatient injuries. We examined the association between persistent polypharmacy and treated fall injury risk from inpatient and outpatient settings in community-dwelling older adults. Methods The Health, Aging and Body Composition Study included 1764 community-dwelling adults (age 73.6 ± 2.9 years; 52% women; 38% black) with Medicare Fee-For-Service (FFS) claims at or within 6 months after 1998/99 clinic visit. Incident fall injuries (N = 545 in 4.6 ± 2.9 years) were defined as the initial claim with an ICD-9 fall E-code and non-fracture injury, or fracture code with/without a fall code from 1998/99 clinic visit to 12/31/08. Those without fall injury (N = 1219) were followed for 8.1 ± 2.6 years. Stepwise Cox models of fall injury risk with a time-varying variable for persistent polypharmacy (defined as ≥6 prescription medications at the two most recent consecutive clinic visits) were adjusted for demographics, lifestyle characteristics, chronic conditions, and functional ability. Sensitivity analyses explored if persistent polypharmacy both with and without fall risk increasing drugs (FRID) use were similarly associated with fall injury risk. Results Among 1764 participants, 636 (36%) had persistent polypharmacy over the follow-up period, and 1128 (64%) did not. Fall injury incidence was 38 per 1000 person-years. Persistent polypharmacy increased fall injury risk (hazard ratio [HR]: 1.31 [1.06, 1.63]) after adjusting for covariates. Persistent polypharmacy with FRID use was associated with a 48% increase in fall injury risk (95%CI: 1.10, 2.00) vs. those who had non-persistent polypharmacy without FRID use. Risks for persistent polypharmacy without FRID use (HR: 1.22 [0.93, 1.60]) and non-persistent polypharmacy with FRID use (HR: 1.08 [0.77, 1.51]) did not significantly increase compared to non-persistent polypharmacy without FRID use. Conclusions Persistent polypharmacy, particularly combined with FRID use, was associated with increased risk for treated fall injuries from inpatient and outpatient settings. Clinicians may need to consider medication management for FRID and other fall prevention strategies in community-dwelling older adults with persistent polypharmacy to reduce fall injury risk.
Background Older adults receive treatment for fall injuries in both inpatient and outpatient settings. The effect of persistent polypharmacy (i.e. using multiple medications over a long period) on fall injuries is understudied, particularly for outpatient injuries. We examined the association between persistent polypharmacy and treated fall injury risk from inpatient and outpatient settings in community-dwelling older adults. Methods The Health, Aging and Body Composition Study included 1764 community-dwelling adults (age 73.6 [+ or -] 2.9 years; 52% women; 38% black) with Medicare Fee-For-Service (FFS) claims at or within 6 months after 1998/99 clinic visit. Incident fall injuries (N = 545 in 4.6 [+ or -] 2.9 years) were defined as the initial claim with an ICD-9 fall E-code and non-fracture injury, or fracture code with/without a fall code from 1998/99 clinic visit to 12/31/08. Those without fall injury (N = 1219) were followed for 8.1 [+ or -] 2.6 years. Stepwise Cox models of fall injury risk with a time-varying variable for persistent polypharmacy (defined as [greater than or equai to]6 prescription medications at the two most recent consecutive clinic visits) were adjusted for demographics, lifestyle characteristics, chronic conditions, and functional ability. Sensitivity analyses explored if persistent polypharmacy both with and without fall risk increasing drugs (FRID) use were similarly associated with fall injury risk. Results Among 1764 participants, 636 (36%) had persistent polypharmacy over the follow-up period, and 1128 (64%) did not. Fall injury incidence was 38 per 1000 person-years. Persistent polypharmacy increased fall injury risk (hazard ratio [HR]: 1.31 [1.06, 1.63]) after adjusting for covariates. Persistent polypharmacy with FRID use was associated with a 48% increase in fall injury risk (95%CI: 1.10, 2.00) vs. those who had non-persistent polypharmacy without FRID use. Risks for persistent polypharmacy without FRID use (HR: 1.22 [0.93, 1.60]) and non-persistent polypharmacy with FRID use (HR: 1.08 [0.77, 1.51]) did not significantly increase compared to non-persistent polypharmacy without FRID use. Conclusions Persistent polypharmacy, particularly combined with FRID use, was associated with increased risk for treated fall injuries from inpatient and outpatient settings. Clinicians may need to consider medication management for FRID and other fall prevention strategies in community-dwelling older adults with persistent polypharmacy to reduce fall injury risk. Keywords: Persistent polypharmacy, Treated fall injury, Medicare, Medication, Falls, FRID, Geriatrics
Older adults receive treatment for fall injuries in both inpatient and outpatient settings. The effect of persistent polypharmacy (i.e. using multiple medications over a long period) on fall injuries is understudied, particularly for outpatient injuries. We examined the association between persistent polypharmacy and treated fall injury risk from inpatient and outpatient settings in community-dwelling older adults.BACKGROUNDOlder adults receive treatment for fall injuries in both inpatient and outpatient settings. The effect of persistent polypharmacy (i.e. using multiple medications over a long period) on fall injuries is understudied, particularly for outpatient injuries. We examined the association between persistent polypharmacy and treated fall injury risk from inpatient and outpatient settings in community-dwelling older adults.The Health, Aging and Body Composition Study included 1764 community-dwelling adults (age 73.6 ± 2.9 years; 52% women; 38% black) with Medicare Fee-For-Service (FFS) claims at or within 6 months after 1998/99 clinic visit. Incident fall injuries (N = 545 in 4.6 ± 2.9 years) were defined as the initial claim with an ICD-9 fall E-code and non-fracture injury, or fracture code with/without a fall code from 1998/99 clinic visit to 12/31/08. Those without fall injury (N = 1219) were followed for 8.1 ± 2.6 years. Stepwise Cox models of fall injury risk with a time-varying variable for persistent polypharmacy (defined as ≥6 prescription medications at the two most recent consecutive clinic visits) were adjusted for demographics, lifestyle characteristics, chronic conditions, and functional ability. Sensitivity analyses explored if persistent polypharmacy both with and without fall risk increasing drugs (FRID) use were similarly associated with fall injury risk.METHODSThe Health, Aging and Body Composition Study included 1764 community-dwelling adults (age 73.6 ± 2.9 years; 52% women; 38% black) with Medicare Fee-For-Service (FFS) claims at or within 6 months after 1998/99 clinic visit. Incident fall injuries (N = 545 in 4.6 ± 2.9 years) were defined as the initial claim with an ICD-9 fall E-code and non-fracture injury, or fracture code with/without a fall code from 1998/99 clinic visit to 12/31/08. Those without fall injury (N = 1219) were followed for 8.1 ± 2.6 years. Stepwise Cox models of fall injury risk with a time-varying variable for persistent polypharmacy (defined as ≥6 prescription medications at the two most recent consecutive clinic visits) were adjusted for demographics, lifestyle characteristics, chronic conditions, and functional ability. Sensitivity analyses explored if persistent polypharmacy both with and without fall risk increasing drugs (FRID) use were similarly associated with fall injury risk.Among 1764 participants, 636 (36%) had persistent polypharmacy over the follow-up period, and 1128 (64%) did not. Fall injury incidence was 38 per 1000 person-years. Persistent polypharmacy increased fall injury risk (hazard ratio [HR]: 1.31 [1.06, 1.63]) after adjusting for covariates. Persistent polypharmacy with FRID use was associated with a 48% increase in fall injury risk (95%CI: 1.10, 2.00) vs. those who had non-persistent polypharmacy without FRID use. Risks for persistent polypharmacy without FRID use (HR: 1.22 [0.93, 1.60]) and non-persistent polypharmacy with FRID use (HR: 1.08 [0.77, 1.51]) did not significantly increase compared to non-persistent polypharmacy without FRID use.RESULTSAmong 1764 participants, 636 (36%) had persistent polypharmacy over the follow-up period, and 1128 (64%) did not. Fall injury incidence was 38 per 1000 person-years. Persistent polypharmacy increased fall injury risk (hazard ratio [HR]: 1.31 [1.06, 1.63]) after adjusting for covariates. Persistent polypharmacy with FRID use was associated with a 48% increase in fall injury risk (95%CI: 1.10, 2.00) vs. those who had non-persistent polypharmacy without FRID use. Risks for persistent polypharmacy without FRID use (HR: 1.22 [0.93, 1.60]) and non-persistent polypharmacy with FRID use (HR: 1.08 [0.77, 1.51]) did not significantly increase compared to non-persistent polypharmacy without FRID use.Persistent polypharmacy, particularly combined with FRID use, was associated with increased risk for treated fall injuries from inpatient and outpatient settings. Clinicians may need to consider medication management for FRID and other fall prevention strategies in community-dwelling older adults with persistent polypharmacy to reduce fall injury risk.CONCLUSIONSPersistent polypharmacy, particularly combined with FRID use, was associated with increased risk for treated fall injuries from inpatient and outpatient settings. Clinicians may need to consider medication management for FRID and other fall prevention strategies in community-dwelling older adults with persistent polypharmacy to reduce fall injury risk.
Background Older adults receive treatment for fall injuries in both inpatient and outpatient settings. The effect of persistent polypharmacy (i.e. using multiple medications over a long period) on fall injuries is understudied, particularly for outpatient injuries. We examined the association between persistent polypharmacy and treated fall injury risk from inpatient and outpatient settings in community-dwelling older adults. Methods The Health, Aging and Body Composition Study included 1764 community-dwelling adults (age 73.6 ± 2.9 years; 52% women; 38% black) with Medicare Fee-For-Service (FFS) claims at or within 6 months after 1998/99 clinic visit. Incident fall injuries ( N  = 545 in 4.6 ± 2.9 years) were defined as the initial claim with an ICD-9 fall E-code and non-fracture injury, or fracture code with/without a fall code from 1998/99 clinic visit to 12/31/08. Those without fall injury ( N  = 1219) were followed for 8.1 ± 2.6 years. Stepwise Cox models of fall injury risk with a time-varying variable for persistent polypharmacy (defined as ≥6 prescription medications at the two most recent consecutive clinic visits) were adjusted for demographics, lifestyle characteristics, chronic conditions, and functional ability. Sensitivity analyses explored if persistent polypharmacy both with and without fall risk increasing drugs (FRID) use were similarly associated with fall injury risk. Results Among 1764 participants, 636 (36%) had persistent polypharmacy over the follow-up period, and 1128 (64%) did not. Fall injury incidence was 38 per 1000 person-years. Persistent polypharmacy increased fall injury risk (hazard ratio [HR]: 1.31 [1.06, 1.63]) after adjusting for covariates. Persistent polypharmacy with FRID use was associated with a 48% increase in fall injury risk (95%CI: 1.10, 2.00) vs. those who had non-persistent polypharmacy without FRID use. Risks for persistent polypharmacy without FRID use (HR: 1.22 [0.93, 1.60]) and non-persistent polypharmacy with FRID use (HR: 1.08 [0.77, 1.51]) did not significantly increase compared to non-persistent polypharmacy without FRID use. Conclusions Persistent polypharmacy, particularly combined with FRID use, was associated with increased risk for treated fall injuries from inpatient and outpatient settings. Clinicians may need to consider medication management for FRID and other fall prevention strategies in community-dwelling older adults with persistent polypharmacy to reduce fall injury risk.
Older adults receive treatment for fall injuries in both inpatient and outpatient settings. The effect of persistent polypharmacy (i.e. using multiple medications over a long period) on fall injuries is understudied, particularly for outpatient injuries. We examined the association between persistent polypharmacy and treated fall injury risk from inpatient and outpatient settings in community-dwelling older adults. The Health, Aging and Body Composition Study included 1764 community-dwelling adults (age 73.6 [+ or -] 2.9 years; 52% women; 38% black) with Medicare Fee-For-Service (FFS) claims at or within 6 months after 1998/99 clinic visit. Incident fall injuries (N = 545 in 4.6 [+ or -] 2.9 years) were defined as the initial claim with an ICD-9 fall E-code and non-fracture injury, or fracture code with/without a fall code from 1998/99 clinic visit to 12/31/08. Those without fall injury (N = 1219) were followed for 8.1 [+ or -] 2.6 years. Stepwise Cox models of fall injury risk with a time-varying variable for persistent polypharmacy (defined as [greater than or equai to]6 prescription medications at the two most recent consecutive clinic visits) were adjusted for demographics, lifestyle characteristics, chronic conditions, and functional ability. Sensitivity analyses explored if persistent polypharmacy both with and without fall risk increasing drugs (FRID) use were similarly associated with fall injury risk. Among 1764 participants, 636 (36%) had persistent polypharmacy over the follow-up period, and 1128 (64%) did not. Fall injury incidence was 38 per 1000 person-years. Persistent polypharmacy increased fall injury risk (hazard ratio [HR]: 1.31 [1.06, 1.63]) after adjusting for covariates. Persistent polypharmacy with FRID use was associated with a 48% increase in fall injury risk (95%CI: 1.10, 2.00) vs. those who had non-persistent polypharmacy without FRID use. Risks for persistent polypharmacy without FRID use (HR: 1.22 [0.93, 1.60]) and non-persistent polypharmacy with FRID use (HR: 1.08 [0.77, 1.51]) did not significantly increase compared to non-persistent polypharmacy without FRID use. Persistent polypharmacy, particularly combined with FRID use, was associated with increased risk for treated fall injuries from inpatient and outpatient settings. Clinicians may need to consider medication management for FRID and other fall prevention strategies in community-dwelling older adults with persistent polypharmacy to reduce fall injury risk.
Abstract Background Older adults receive treatment for fall injuries in both inpatient and outpatient settings. The effect of persistent polypharmacy (i.e. using multiple medications over a long period) on fall injuries is understudied, particularly for outpatient injuries. We examined the association between persistent polypharmacy and treated fall injury risk from inpatient and outpatient settings in community-dwelling older adults. Methods The Health, Aging and Body Composition Study included 1764 community-dwelling adults (age 73.6 ± 2.9 years; 52% women; 38% black) with Medicare Fee-For-Service (FFS) claims at or within 6 months after 1998/99 clinic visit. Incident fall injuries (N = 545 in 4.6 ± 2.9 years) were defined as the initial claim with an ICD-9 fall E-code and non-fracture injury, or fracture code with/without a fall code from 1998/99 clinic visit to 12/31/08. Those without fall injury (N = 1219) were followed for 8.1 ± 2.6 years. Stepwise Cox models of fall injury risk with a time-varying variable for persistent polypharmacy (defined as ≥6 prescription medications at the two most recent consecutive clinic visits) were adjusted for demographics, lifestyle characteristics, chronic conditions, and functional ability. Sensitivity analyses explored if persistent polypharmacy both with and without fall risk increasing drugs (FRID) use were similarly associated with fall injury risk. Results Among 1764 participants, 636 (36%) had persistent polypharmacy over the follow-up period, and 1128 (64%) did not. Fall injury incidence was 38 per 1000 person-years. Persistent polypharmacy increased fall injury risk (hazard ratio [HR]: 1.31 [1.06, 1.63]) after adjusting for covariates. Persistent polypharmacy with FRID use was associated with a 48% increase in fall injury risk (95%CI: 1.10, 2.00) vs. those who had non-persistent polypharmacy without FRID use. Risks for persistent polypharmacy without FRID use (HR: 1.22 [0.93, 1.60]) and non-persistent polypharmacy with FRID use (HR: 1.08 [0.77, 1.51]) did not significantly increase compared to non-persistent polypharmacy without FRID use. Conclusions Persistent polypharmacy, particularly combined with FRID use, was associated with increased risk for treated fall injuries from inpatient and outpatient settings. Clinicians may need to consider medication management for FRID and other fall prevention strategies in community-dwelling older adults with persistent polypharmacy to reduce fall injury risk.
Older adults receive treatment for fall injuries in both inpatient and outpatient settings. The effect of persistent polypharmacy (i.e. using multiple medications over a long period) on fall injuries is understudied, particularly for outpatient injuries. We examined the association between persistent polypharmacy and treated fall injury risk from inpatient and outpatient settings in community-dwelling older adults. The Health, Aging and Body Composition Study included 1764 community-dwelling adults (age 73.6 ± 2.9 years; 52% women; 38% black) with Medicare Fee-For-Service (FFS) claims at or within 6 months after 1998/99 clinic visit. Incident fall injuries (N = 545 in 4.6 ± 2.9 years) were defined as the initial claim with an ICD-9 fall E-code and non-fracture injury, or fracture code with/without a fall code from 1998/99 clinic visit to 12/31/08. Those without fall injury (N = 1219) were followed for 8.1 ± 2.6 years. Stepwise Cox models of fall injury risk with a time-varying variable for persistent polypharmacy (defined as ≥6 prescription medications at the two most recent consecutive clinic visits) were adjusted for demographics, lifestyle characteristics, chronic conditions, and functional ability. Sensitivity analyses explored if persistent polypharmacy both with and without fall risk increasing drugs (FRID) use were similarly associated with fall injury risk. Among 1764 participants, 636 (36%) had persistent polypharmacy over the follow-up period, and 1128 (64%) did not. Fall injury incidence was 38 per 1000 person-years. Persistent polypharmacy increased fall injury risk (hazard ratio [HR]: 1.31 [1.06, 1.63]) after adjusting for covariates. Persistent polypharmacy with FRID use was associated with a 48% increase in fall injury risk (95%CI: 1.10, 2.00) vs. those who had non-persistent polypharmacy without FRID use. Risks for persistent polypharmacy without FRID use (HR: 1.22 [0.93, 1.60]) and non-persistent polypharmacy with FRID use (HR: 1.08 [0.77, 1.51]) did not significantly increase compared to non-persistent polypharmacy without FRID use. Persistent polypharmacy, particularly combined with FRID use, was associated with increased risk for treated fall injuries from inpatient and outpatient settings. Clinicians may need to consider medication management for FRID and other fall prevention strategies in community-dwelling older adults with persistent polypharmacy to reduce fall injury risk.
ArticleNumber 710
Audience Academic
Author Donohue, Julie M.
Marcum, Zachary A.
Costacou, Tina
Boudreau, Robert M.
Xue, Lingshu
Waters, Teresa M.
Zgibor, Janice C.
Newman, Anne B.
Strotmeyer, Elsa S.
Author_xml – sequence: 1
  givenname: Lingshu
  surname: Xue
  fullname: Xue, Lingshu
  organization: Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh
– sequence: 2
  givenname: Robert M.
  surname: Boudreau
  fullname: Boudreau, Robert M.
  organization: Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh
– sequence: 3
  givenname: Julie M.
  surname: Donohue
  fullname: Donohue, Julie M.
  organization: Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh
– sequence: 4
  givenname: Janice C.
  surname: Zgibor
  fullname: Zgibor, Janice C.
  organization: College of Public Health, University of South Florida
– sequence: 5
  givenname: Zachary A.
  surname: Marcum
  fullname: Marcum, Zachary A.
  organization: Department of Pharmacy, School of Pharmacy, University of Washington
– sequence: 6
  givenname: Tina
  surname: Costacou
  fullname: Costacou, Tina
  organization: Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh
– sequence: 7
  givenname: Anne B.
  surname: Newman
  fullname: Newman, Anne B.
  organization: Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh
– sequence: 8
  givenname: Teresa M.
  surname: Waters
  fullname: Waters, Teresa M.
  organization: Department of Health Management and Policy, University of Kentucky College of Public Health
– sequence: 9
  givenname: Elsa S.
  surname: Strotmeyer
  fullname: Strotmeyer, Elsa S.
  email: strotmeyere@edc.pitt.edu
  organization: Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34911467$$D View this record in MEDLINE/PubMed
BookMark eNp9kktv1DAUhSNURB_wB1igSGxYkGI7frJAGkZAK1UCCdiwsRzHyXhI7NROkPLvcWZK26lQFUWxnHO-63t9TrMj553JspcQnEPI6bsIEWesAAimlwpSiCfZCcQMFqiE_Oje-jg7jXELAGQc0WfZcYkFhJiyk-zXNxOijaNxYz74bh42KvRKz7lydd6orsut205hzoONv9_n48bkF0Z14-Ztvmqta3e6j76e87XvBx_taL3Lv49TPT_PniZANC9uvmfZz8-ffqwviquvXy7Xq6tCU8DGoqZEobLiCGNWqUowwxiAwGgjBIBQE8awARhDXXGuNVSQoFohosvUeMOr8iy73HNrr7ZyCLZXYZZeWbnb8KGVKoxWd0Y2GgBDTMMaSrFWqAIEYlArlrhYaJhYH_asYap6U-s0lqC6A-jhH2c3svV_JKeMYEoT4M0NIPjrycRR9jZq03XKGT9FiSgEAiJCllqvH0i3fgoujWpRpbsFQIg7VatSA9Y1PtXVC1SuqCgJ5aVYWOf_UaWnNr3VKTaNTfsHhlf3G73t8F8ykgDtBTr4GINpbiUQyCV-ch8_mW5B7uInl8PyByZtR7VEIh3Hdo9by701pjquNeFuGo-4_gKKSOy0
CitedBy_id crossref_primary_10_1590_0034_7167_2023_0454
crossref_primary_10_1071_HC24038
crossref_primary_10_1016_j_exger_2023_112317
crossref_primary_10_1186_s12877_024_05301_w
crossref_primary_10_3389_fpubh_2023_973827
crossref_primary_10_1016_j_suc_2023_06_003
crossref_primary_10_1016_j_archger_2023_105127
crossref_primary_10_1016_j_mad_2024_111929
crossref_primary_10_3390_ijms24119760
crossref_primary_10_1093_gerona_glac116
crossref_primary_10_1016_j_bone_2024_117366
crossref_primary_10_1097_01_NPR_0000000000000138
crossref_primary_10_1186_s40545_023_00621_5
crossref_primary_10_35693_2500_1388_2022_7_4_220_225
crossref_primary_10_1371_journal_pone_0305735
crossref_primary_10_3389_fpubh_2023_1068314
crossref_primary_10_1093_geroni_igae051
crossref_primary_10_1007_s00228_024_03776_5
crossref_primary_10_1089_jpm_2024_0215
crossref_primary_10_1186_s40621_023_00418_9
crossref_primary_10_1097_GH9_0000000000000305
crossref_primary_10_1186_s12889_024_20939_2
crossref_primary_10_1590_0034_7167_2023_0454pt
crossref_primary_10_33192_smj_v77i1_271422
crossref_primary_10_1007_s40266_022_00985_4
crossref_primary_10_3389_fphar_2022_1044744
Cites_doi 10.1016/S0378-5122(00)00149-3
10.1016/j.jsr.2016.05.001
10.1111/j.1532-5415.2005.53514.x
10.1007/s00228-021-03207-9
10.1186/s40621-017-0114-y
10.1111/j.1532-5415.2010.02770.x
10.1136/ip.2004.005835
10.1177/1060028015596998
10.1111/j.1532-5415.2005.53501.x
10.1097/MD.0b013e3181f15efc
10.1007/s00228-013-1495-7
10.1111/jgs.13702
10.1016/j.apmr.2017.01.014
10.1002/pds.1712
10.1016/j.clinph.2012.07.027
10.1111/j.1447-0594.2011.00703.x
10.1111/jgs.15717
10.1186/1471-2318-14-92
10.2337/dc08-0433
10.1249/00005768-199301000-00011
10.2174/092986710790416326
10.1111/jgs.15317
10.1111/j.1532-5415.2009.02487.x
10.1007/BF01719664
10.1111/j.1532-5415.2010.03234.x
10.1007/s10433-017-0449-9
10.1111/j.1532-5415.2005.53257.x
10.2147/CLEP.S153458
10.1001/jama.2018.3097
10.1016/S0140-6736(05)67604-0
10.1111/j.1365-2125.2005.02543.x
10.1176/ajp.140.1.41
10.1136/bmjopen-2019-035978
10.1007/s11999-011-1863-5
10.1001/archinternmed.2009.357
10.1007/s40615-017-0367-8
10.2337/dc19-S002
10.1016/j.annemergmed.2020.07.025
10.1056/NEJM198812293192604
10.1093/oxfordjournals.aje.a116681
10.1186/s12877-017-0621-2
10.1093/ageing/afv173
10.1186/s40621-015-0066-z
10.1046/j.1365-2389.2003.51267.x
10.1093/gerona/53A.4.M264
10.1093/ageing/afaa249
10.2337/db05-1183
10.1007/s00198-005-0032-7
10.1177/2042098615615472
10.1371/journal.pone.0123390
10.2165/0002512-200825120-00004
10.2147/CLEP.S201614
10.1111/j.1532-5415.2004.52575.x
10.1186/s12889-020-09920-x
10.1371/journal.pone.0150939
10.1177/2042098611400332
10.3389/fphar.2018.00120
10.1186/s12913-019-4149-3
10.1093/gerona/glv095
10.1093/gerona/gln043
10.1681/ASN.2005050545
10.1007/s40520-018-1004-z
ContentType Journal Article
Copyright The Author(s) 2021
2021. The Author(s).
COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2021
– notice: 2021. The Author(s).
– notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7TK
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s12877-021-02695-9
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

MEDLINE - Academic



MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ (Directory of Open Access Journals)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2318
EndPage 10
ExternalDocumentID oai_doaj_org_article_fc00e5ef7f664ca2b05140da7cc149c1
PMC8675466
A693568391
34911467
10_1186_s12877_021_02695_9
Genre Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
United States--US
Pittsburgh Pennsylvania
GeographicLocations_xml – name: United States
– name: United States--US
– name: Pittsburgh Pennsylvania
GroupedDBID ---
0R~
23N
2WC
53G
5GY
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABUWG
ACGFO
ACGFS
ACHQT
ACIHN
ACPRK
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
ALIPV
CITATION
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7QP
7TK
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c607t-d65a23b82447bab97e77010ece99011c5774e0441cb88cc1a152da25c3021f8b3
IEDL.DBID M48
ISSN 1471-2318
IngestDate Wed Aug 27 01:20:40 EDT 2025
Thu Aug 21 18:10:54 EDT 2025
Fri Sep 05 10:09:24 EDT 2025
Fri Jul 25 05:48:19 EDT 2025
Tue Jun 17 21:05:34 EDT 2025
Tue Jun 10 20:39:43 EDT 2025
Thu Jan 02 22:57:05 EST 2025
Tue Jul 01 04:31:08 EDT 2025
Thu Apr 24 23:01:24 EDT 2025
Sat Sep 06 07:29:45 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Falls
Persistent polypharmacy
Medicare
FRID
Treated fall injury
Medication
Geriatrics
Language English
License 2021. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c607t-d65a23b82447bab97e77010ece99011c5774e0441cb88cc1a152da25c3021f8b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doi.org/10.1186/s12877-021-02695-9
PMID 34911467
PQID 2611280099
PQPubID 44817
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_fc00e5ef7f664ca2b05140da7cc149c1
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8675466
proquest_miscellaneous_2610912551
proquest_journals_2611280099
gale_infotracmisc_A693568391
gale_infotracacademiconefile_A693568391
pubmed_primary_34911467
crossref_primary_10_1186_s12877_021_02695_9
crossref_citationtrail_10_1186_s12877_021_02695_9
springer_journals_10_1186_s12877_021_02695_9
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-12-15
PublicationDateYYYYMMDD 2021-12-15
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-15
  day: 15
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC geriatrics
PublicationTitleAbbrev BMC Geriatr
PublicationTitleAlternate BMC Geriatr
PublicationYear 2021
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References YJ Wang (2695_CR10) 2018; 9
M Pahor (2695_CR23) 1994; 10
JL O’Loughlin (2695_CR1) 1993; 137
2695_CR64
L Laflamme (2695_CR32) 2015; 10
USPST Force (2695_CR50) 2018; 319
A Corsonello (2695_CR43) 2010; 17
KA Faulkner (2695_CR56) 2005; 53
N Masnoon (2695_CR6) 2017; 17
J Lee (2695_CR47) 2021; 11
S Kudlacek (2695_CR59) 2000; 36
KM Mehta (2695_CR27) 2004; 52
L Morin (2695_CR36) 2019; 11
ES Strotmeyer (2695_CR41) 2009; 57
SB Kim (2695_CR35) 2016; 3
ER Burns (2695_CR5) 2016; 58
B Helgadottir (2695_CR9) 2014; 14
LE Griffith (2695_CR38) 2019; 19
MG Shlipak (2695_CR28) 2006; 17
JC Woolcott (2695_CR17) 2009; 169
ES Strotmeyer (2695_CR63) 2010; 58
2695_CR4
C Franchi (2695_CR13) 2013; 69
N Sagawa (2695_CR21) 2018; 15
S Iyer (2695_CR49) 2008; 25
M Cesari (2695_CR30) 2005; 53
ZA Marcum (2695_CR16) 2015; 49
LJ Seppala (2695_CR44) 2018; 19
American Diabetes A (2695_CR25) 2019; 42
Panel on Prevention of Falls in Older Persons AGS, British Geriatrics S (2695_CR46) 2011; 59
JW Wastesson (2695_CR11) 2019; 67
JT Hanlon (2695_CR15) 2009; 64
G Ziere (2695_CR18) 2006; 61
C Beer (2695_CR48) 2011; 2
P Zaninotto (2695_CR33) 2020; 20
L Morin (2695_CR37) 2018; 10
MJ Rawle (2695_CR14) 2018; 66
ES Strotmeyer (2695_CR42) 2008; 31
JA Stevens (2695_CR55) 2005; 11
BJ Vellas (2695_CR8) 1998; 53
M Visser (2695_CR31) 2005; 53
AE Salter (2695_CR51) 2006; 17
DQ Sun (2695_CR58) 2016; 45
EM Goldberg (2695_CR53) 2020; 76
ZA Marcum (2695_CR22) 2015; 70
P Kannus (2695_CR3) 2005; 366
DB Matchar (2695_CR54) 2017; 98
SK Verma (2695_CR62) 2016; 11
DC Chan (2695_CR12) 2009; 18
N de Rekeneire (2695_CR20) 2003; 51
SW Park (2695_CR40) 2006; 55
SC Kwon (2695_CR57) 2018; 5
KN Shankar (2695_CR52) 2017; 4
JA Cauley (2695_CR60) 2011; 469
ME Tinetti (2695_CR2) 1988; 319
By the American Geriatrics Society Beers Criteria Update Expert P (2695_CR19) 2015; 63
T Kojima (2695_CR61) 2011; 11
RE Roberts (2695_CR26) 1983; 140
BE Ainsworth (2695_CR24) 1993; 25
RE Ward (2695_CR29) 2013; 124
LJ Seppala (2695_CR34) 2021; 50
AH Lavan (2695_CR45) 2016; 7
SW Lai (2695_CR7) 2010; 89
AL Mazya (2695_CR39) 2019; 31
References_xml – volume: 36
  start-page: 173
  issue: 3
  year: 2000
  ident: 2695_CR59
  publication-title: Maturitas
  doi: 10.1016/S0378-5122(00)00149-3
– volume: 58
  start-page: 99
  year: 2016
  ident: 2695_CR5
  publication-title: J Saf Res
  doi: 10.1016/j.jsr.2016.05.001
– volume: 53
  start-page: 1774
  issue: 10
  year: 2005
  ident: 2695_CR56
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.2005.53514.x
– ident: 2695_CR64
  doi: 10.1007/s00228-021-03207-9
– volume: 4
  start-page: 18
  issue: 1
  year: 2017
  ident: 2695_CR52
  publication-title: Inj Epidemiol
  doi: 10.1186/s40621-017-0114-y
– volume: 58
  start-page: 696
  issue: 4
  year: 2010
  ident: 2695_CR63
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.2010.02770.x
– volume: 11
  start-page: 115
  issue: 2
  year: 2005
  ident: 2695_CR55
  publication-title: Inj Prev
  doi: 10.1136/ip.2004.005835
– ident: 2695_CR4
– volume: 49
  start-page: 1214
  issue: 11
  year: 2015
  ident: 2695_CR16
  publication-title: Ann Pharmacother
  doi: 10.1177/1060028015596998
– volume: 53
  start-page: 1675
  issue: 10
  year: 2005
  ident: 2695_CR30
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.2005.53501.x
– volume: 89
  start-page: 295
  issue: 5
  year: 2010
  ident: 2695_CR7
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0b013e3181f15efc
– volume: 69
  start-page: 1477
  issue: 7
  year: 2013
  ident: 2695_CR13
  publication-title: Eur J Clin Pharmacol
  doi: 10.1007/s00228-013-1495-7
– volume: 63
  start-page: 2227
  issue: 11
  year: 2015
  ident: 2695_CR19
  publication-title: J Am Geriatr Soc
  doi: 10.1111/jgs.13702
– volume: 19
  start-page: 372.e371
  issue: 4
  year: 2018
  ident: 2695_CR44
  publication-title: J Am Med Dir Assoc
– volume: 98
  start-page: 1086
  issue: 6
  year: 2017
  ident: 2695_CR54
  publication-title: Arch Phys Med Rehabil
  doi: 10.1016/j.apmr.2017.01.014
– volume: 18
  start-page: 327
  issue: 4
  year: 2009
  ident: 2695_CR12
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.1712
– volume: 124
  start-page: 603
  issue: 3
  year: 2013
  ident: 2695_CR29
  publication-title: Clin Neurophysiol
  doi: 10.1016/j.clinph.2012.07.027
– volume: 11
  start-page: 438
  issue: 4
  year: 2011
  ident: 2695_CR61
  publication-title: Geriatr Gerontol Int
  doi: 10.1111/j.1447-0594.2011.00703.x
– volume: 67
  start-page: 455
  issue: 3
  year: 2019
  ident: 2695_CR11
  publication-title: J Am Geriatr Soc
  doi: 10.1111/jgs.15717
– volume: 14
  start-page: 92
  year: 2014
  ident: 2695_CR9
  publication-title: BMC Geriatr
  doi: 10.1186/1471-2318-14-92
– volume: 31
  start-page: 1767
  issue: 9
  year: 2008
  ident: 2695_CR42
  publication-title: Diabetes Care
  doi: 10.2337/dc08-0433
– volume: 25
  start-page: 71
  issue: 1
  year: 1993
  ident: 2695_CR24
  publication-title: Med Sci Sports Exerc
  doi: 10.1249/00005768-199301000-00011
– volume: 17
  start-page: 571
  issue: 6
  year: 2010
  ident: 2695_CR43
  publication-title: Curr Med Chem
  doi: 10.2174/092986710790416326
– volume: 66
  start-page: 916
  issue: 5
  year: 2018
  ident: 2695_CR14
  publication-title: J Am Geriatr Soc
  doi: 10.1111/jgs.15317
– volume: 57
  start-page: 2004
  issue: 11
  year: 2009
  ident: 2695_CR41
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.2009.02487.x
– volume: 10
  start-page: 405
  issue: 4
  year: 1994
  ident: 2695_CR23
  publication-title: Eur J Epidemiol
  doi: 10.1007/BF01719664
– volume: 59
  start-page: 148
  issue: 1
  year: 2011
  ident: 2695_CR46
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.2010.03234.x
– volume: 15
  start-page: 321
  issue: 3
  year: 2018
  ident: 2695_CR21
  publication-title: Eur J Ageing
  doi: 10.1007/s10433-017-0449-9
– volume: 53
  start-page: 762
  issue: 5
  year: 2005
  ident: 2695_CR31
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.2005.53257.x
– volume: 10
  start-page: 289
  year: 2018
  ident: 2695_CR37
  publication-title: Clin Epidemiol
  doi: 10.2147/CLEP.S153458
– volume: 319
  start-page: 1696
  issue: 16
  year: 2018
  ident: 2695_CR50
  publication-title: JAMA
  doi: 10.1001/jama.2018.3097
– volume: 366
  start-page: 1885
  issue: 9500
  year: 2005
  ident: 2695_CR3
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)67604-0
– volume: 61
  start-page: 218
  issue: 2
  year: 2006
  ident: 2695_CR18
  publication-title: Br J Clin Pharmacol
  doi: 10.1111/j.1365-2125.2005.02543.x
– volume: 140
  start-page: 41
  issue: 1
  year: 1983
  ident: 2695_CR26
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.140.1.41
– volume: 11
  start-page: e035978
  issue: 2
  year: 2021
  ident: 2695_CR47
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2019-035978
– volume: 469
  start-page: 1891
  issue: 7
  year: 2011
  ident: 2695_CR60
  publication-title: Clin Orthop Relat Res
  doi: 10.1007/s11999-011-1863-5
– volume: 169
  start-page: 1952
  issue: 21
  year: 2009
  ident: 2695_CR17
  publication-title: Arch Intern Med
  doi: 10.1001/archinternmed.2009.357
– volume: 5
  start-page: 271
  issue: 2
  year: 2018
  ident: 2695_CR57
  publication-title: J Racial Ethn Health Disparities
  doi: 10.1007/s40615-017-0367-8
– volume: 42
  start-page: S13
  issue: Suppl 1
  year: 2019
  ident: 2695_CR25
  publication-title: Diabetes Care
  doi: 10.2337/dc19-S002
– volume: 76
  start-page: 739
  issue: 6
  year: 2020
  ident: 2695_CR53
  publication-title: Ann Emerg Med
  doi: 10.1016/j.annemergmed.2020.07.025
– volume: 319
  start-page: 1701
  issue: 26
  year: 1988
  ident: 2695_CR2
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198812293192604
– volume: 137
  start-page: 342
  issue: 3
  year: 1993
  ident: 2695_CR1
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a116681
– volume: 17
  start-page: 230
  issue: 1
  year: 2017
  ident: 2695_CR6
  publication-title: BMC Geriatr
  doi: 10.1186/s12877-017-0621-2
– volume: 45
  start-page: 120
  issue: 1
  year: 2016
  ident: 2695_CR58
  publication-title: Age Ageing
  doi: 10.1093/ageing/afv173
– volume: 3
  start-page: 1
  issue: 1
  year: 2016
  ident: 2695_CR35
  publication-title: Inj Epidemiol
  doi: 10.1186/s40621-015-0066-z
– volume: 51
  start-page: 841
  issue: 6
  year: 2003
  ident: 2695_CR20
  publication-title: J Am Geriatr Soc
  doi: 10.1046/j.1365-2389.2003.51267.x
– volume: 53
  start-page: M264
  issue: 4
  year: 1998
  ident: 2695_CR8
  publication-title: J Gerontol A Biol Sci Med Sci
  doi: 10.1093/gerona/53A.4.M264
– volume: 50
  start-page: 1189
  issue: 4
  year: 2021
  ident: 2695_CR34
  publication-title: Age Ageing
  doi: 10.1093/ageing/afaa249
– volume: 55
  start-page: 1813
  issue: 6
  year: 2006
  ident: 2695_CR40
  publication-title: Diabetes
  doi: 10.2337/db05-1183
– volume: 17
  start-page: 672
  issue: 5
  year: 2006
  ident: 2695_CR51
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-005-0032-7
– volume: 7
  start-page: 11
  issue: 1
  year: 2016
  ident: 2695_CR45
  publication-title: Ther Adv Drug Saf
  doi: 10.1177/2042098615615472
– volume: 10
  start-page: e0123390
  issue: 3
  year: 2015
  ident: 2695_CR32
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0123390
– volume: 25
  start-page: 1021
  issue: 12
  year: 2008
  ident: 2695_CR49
  publication-title: Drugs Aging
  doi: 10.2165/0002512-200825120-00004
– volume: 11
  start-page: 483
  year: 2019
  ident: 2695_CR36
  publication-title: Clin Epidemiol
  doi: 10.2147/CLEP.S201614
– volume: 52
  start-page: 2120
  issue: 12
  year: 2004
  ident: 2695_CR27
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.2004.52575.x
– volume: 20
  start-page: 1804
  issue: 1
  year: 2020
  ident: 2695_CR33
  publication-title: BMC Public Health
  doi: 10.1186/s12889-020-09920-x
– volume: 11
  start-page: e0150939
  issue: 3
  year: 2016
  ident: 2695_CR62
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0150939
– volume: 2
  start-page: 37
  issue: 2
  year: 2011
  ident: 2695_CR48
  publication-title: Ther Adv Drug Saf
  doi: 10.1177/2042098611400332
– volume: 9
  start-page: 120
  year: 2018
  ident: 2695_CR10
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2018.00120
– volume: 19
  start-page: 313
  issue: 1
  year: 2019
  ident: 2695_CR38
  publication-title: BMC Health Serv Res
  doi: 10.1186/s12913-019-4149-3
– volume: 70
  start-page: 1562
  issue: 12
  year: 2015
  ident: 2695_CR22
  publication-title: J Gerontol A Biol Sci Med Sci
  doi: 10.1093/gerona/glv095
– volume: 64
  start-page: 492
  issue: 4
  year: 2009
  ident: 2695_CR15
  publication-title: J Gerontol A Biol Sci Med Sci
  doi: 10.1093/gerona/gln043
– volume: 17
  start-page: 254
  issue: 1
  year: 2006
  ident: 2695_CR28
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2005050545
– volume: 31
  start-page: 519
  issue: 4
  year: 2019
  ident: 2695_CR39
  publication-title: Aging Clin Exp Res
  doi: 10.1007/s40520-018-1004-z
SSID ssj0017826
Score 2.4360592
Snippet Background Older adults receive treatment for fall injuries in both inpatient and outpatient settings. The effect of persistent polypharmacy (i.e. using...
Older adults receive treatment for fall injuries in both inpatient and outpatient settings. The effect of persistent polypharmacy (i.e. using multiple...
Background Older adults receive treatment for fall injuries in both inpatient and outpatient settings. The effect of persistent polypharmacy (i.e. using...
Abstract Background Older adults receive treatment for fall injuries in both inpatient and outpatient settings. The effect of persistent polypharmacy (i.e....
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 710
SubjectTerms Accidental Falls
Aged
Aging
Antidepressants
Benzodiazepines
Body Composition
Chronic illnesses
Codes
Demography
Drugs
Falls
Falls (Accidents)
Female
FRID
Geriatrics
Geriatrics/Gerontology
Humans
Injuries
Injury prevention
Male
Medical records
Medicare
Medication
Medicine
Medicine & Public Health
Narcotics
Older people
Persistent polypharmacy
Physiological aspects
Polypharmacy
Prescribing
Psychotropic drugs
Rehabilitation
Risk Factors
Sensitivity analysis
Treated fall injury
United States - epidemiology
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxUxEA_Sg3gRv12tEkHwYJdmd7NJ1turWIpQTxaKl5BMslh57Hu0r4f33zuTzT67FfXidTNZkplJ5jdkPhh7a3wbG9nrEkCqUgbRlIaCqaQ3wUjnla4pwfn0izo5k5_P2_Mbrb4oJmwsDzwy7rAHIWIbe90rJcHVngp2i-A0AIJ7SI6P6MTkTOX3A7R7akqRMerwCm9hrUsKR0Cfg7oTzsxQqtb_-518wyjdDpi89WqajNHxA3Y_o0i-GFf_kN2JwyN29zS_kz9m3yiwnQQ4bPh6tdyuxwLVW-6GwHu3XPKL4Qdyk1Nk-QeOIJCP-UgHfEFdixLd0SpsOd0XOa6LU8zh9gk7O_709eNJmbsolKCE3pRBta5uvEE7rr3znY5aoxMWIdKTWAUtAsAoEBWBNwaZ6tCiB1e30CC7euObp2xvWA3xOeMRHCIYXzsAIZvgUJRdHZTX-LmKzhWsmphqIZcYp04XS5tcDaPsKAiLf7ZJELYr2PvdnPVYYOOv1Eckqx0lFcdOH1BlbFYZ-y-VKdg7krSlI4zLA5czEXCTVAzLLlTXtAqRI1Luzyjx6MF8eNIVm4_-lUWXFJdNyLtgb3bDNJPC2Ya4uk40iNPQm8NfPBtVa7elRnaUKa4LpmdKN9vzfGS4-J4Kgxv0_qRSBTuY1PPXsv7M0xf_g6cv2b2ajldVl1W7z_Y2l9fxFcK1jX-dTuZP0CY6Rg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3batRAdKhbEF_Eu6lVRhB8sKG5TGYmgsiutBShi4iF4sswt9TKkmzb7cP-vedMJltTsa-ZkyEz555zI-SdNJUvWSNSaxlPmcvKVGIyFTPSSaYNFwUWOB_P-dEJ-3panW6R-VALg2mVg0wMgtp1Fv-R74OlD6IUDZrPy4sUp0ZhdHUYoaHjaAX3KbQYu0e2QSRX2YRszw7m375v4gqgD_lQOiP5_hVsKUSKaQrgi-DUwpF6Cl38_5XVfymr24mUt6KpQUkdPiIPo3VJpz05PCZbvn1C7h_H-PlT8hMT3hGx7Youu8V62TeuXlPdOtroxYKet7_hlilmnH-kYBzSvk5pj05xmlGAm3VuTVGOxHwvirmI62fk5PDgx5ejNE5XSC3PxCp1vNJFaSTod2G0qYUXApwzbz2GynJbgWHoM7CWrJHS2lyDpne6qGwJ19VIUz4nk7Zr_UtCvdVg2ZgCsJCx0mlAcV04bgQ8zr3WCcmHS1U2th7HCRgLFVwQyVWPCAU7q4AIVSfkw-adZd94407oGeJqA4lNs8OD7vJMRR5Ujc0yX_lGNJwzqwuDvd8zpwWcjtU2T8h7xLRC1obPszpWKMAhsUmWmvK6rDhYlAC5O4IElrTj5YFWVBQJV-qGgBPydrOMb2KaW-u76wAD9ht4ebDFi560NkcqWY0V5CIhYkR0ozOPV9rzX6FhuASvkHGekL2BPG8-6_93unP3KV6RBwUyTl6kebVLJqvLa_8aDLSVeRO57g9okDeV
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEA9aQXwRrV-rtUQQfLCL-5Gv9e16tBShPlkovoRkksWWY--w14f7753J7q3dqgVfN5MlycxkZpiZXxh7b7yMtWh1DiBULkJR54aKqYQ3wQjnla6owfn0qzo5E1_O5fkAk0O9MDfz96VRn67w_tQ6p0ICjBboXcH77IHEi5ekea7mY8YALZ3aNsX8dd7E8CR8_j9v4Rtm6HaJ5K08aTI_x0_Y48Fv5LOe0U_ZvdjtsoenQ2b8GftOpezEsm7NV8vFZtVDUm-46wJv3WLBL7pLPD9OteSfObp9vO9AOuAzeqco0R0uw4bTDTFUcnGqMtw8Z2fHR9_mJ_nwbkIOqtDrPCjpqtobtNzaO9_oqDWGXREiJcFKkOjyxQL9IPDGAJQObXhwlYQaj6s1vn7BdrplF18xHsGhz-IrB1CIOjhkXlMF5TV-LqNzGSu3h2phABWnty0WNgUXRtmeERb_bBMjbJOxj-OcVQ-pcSf1IfFqpCQ47PQBpcQO2mVbKIooY6tbpQS4yhOqexGcxt2JBsqMfSBOW1JaXB64ofcAN0nwV3ammloq9BWRcm9CicoG0-GtrNhB2a8sBqG4bPK1M_ZuHKaZVMDWxeV1okHPDOM3_MXLXrTGLdWiod5wnTE9EbrJnqcj3cWPBAVuMN4TSmXsYCuev5f17zN9_X_kb9ijihSprPJS7rGd9c_r-BZdsbXfTzr4CzO-KgM
  priority: 102
  providerName: Springer Nature
Title Persistent polypharmacy and fall injury risk: the Health, Aging and Body Composition Study
URI https://link.springer.com/article/10.1186/s12877-021-02695-9
https://www.ncbi.nlm.nih.gov/pubmed/34911467
https://www.proquest.com/docview/2611280099
https://www.proquest.com/docview/2610912551
https://pubmed.ncbi.nlm.nih.gov/PMC8675466
https://doaj.org/article/fc00e5ef7f664ca2b05140da7cc149c1
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1ra9swUPQBY1_G3vPWBQ0G-7B680OW5MEYSWgpg5ZRFgj9IiRZ7jqMnaUpLP9-d7Kdzl032JdArLOQdHe6O9-LkNfSZC5lpQitZTxkRZSGEoOpmJGFZNpwkWCC8_EJP5qxz_NsvkX6dkfdAV7eatphP6nZsnr388f6EzD8R8_wkr-_hDtWiBCDDcCiwN6D22TX-4swlI9dexVAGrbZRiIOQa-RfRLNrXMMBJWv5__nrf2b2LoZUnnDr-rF1eF9cq_TM-m4JYwHZMvVD8md486T_oicYeg7orhe0UVTrRdtCes11XVBS11V9KL-DudNMfb8AwU1kbYZS_t0jH2NPNykKdYUb5Qu8otiVOL6MZkdHnydHoVdn4XQ8kiswoJnOkmNBEkvjDa5cEKAmeasQ6dZbDNQEV0EepM1Uloba5D5hU4ym8JxldKkT8hO3dTuGaHOatBxTKKtjVhaaEB2nhTcCHgcO60DEveHqmxXhBx7YVTKGyOSqxYRCmZWHhEqD8jbzTuLtgTHP6EniKsNJJbP9g-a5bnquFGVNopc5kpRcs6sTgxWgY8KLWB3LLdxQN4gphWSHSzP6i5XATaJ5bLUmOdpxkG3BMi9ASQwpx0O97SietpWYLTCslE3D8irzTC-iQFvtWuuPAxocmDvwRRPW9LabCllOeaSi4CIAdEN9jwcqS---dLhEuxDxnlA9nvyvF7W38_0-X9h4AW5myAfxUkYZ3tkZ7W8ci9Bc1uZEdkWczEiu5ODky-n8G_KpyP_FWTkGRV-TydnvwAExz9W
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3JbtQw1CpFAi6InUABI4E40KhZHNtBQmgKVFPa6amVRlxcb4GiUTJ0pkL5Kb6R97JMSRG99Ro_W7bfHr-FkFfSZD5lhQitZTxkLkpDicFUzEgnmTZcJJjgPDng4yP2ZZpN18jvPhcGwyp7mdgIaldZ_Ee-BZY-iFI0aD7Mf4bYNQpfV_sWGi1Z7Pn6F7hsi_e7nwC_r5Nk5_Phx3HYdRUILY_EMnQ800lqJOg1YbTJhRcCnBJvPT4RxTYDg8hHYCVYI6W1sQYN53SS2RTUYSFNCuteI9cZPjEC_4jpysGLQdvyPjFH8q0FbFiIEIMgwNPBnogD5df0CPhXE_ylCi-GaV54q21U4M4dcruzXemoJba7ZM2X98iNSfc6f598xXB6JJtySefVrJ63ZbFrqktHCz2b0ZPyB-CQYjz7OwqmJ22zoDbpCHslNXDblaspSqkumoxipGP9gBxdyS0_JOtlVfrHhHqrwW4yibY2YqnTQEB54rgR8Dn2Wgck7i9V2a6wOfbXmKnGwZFctYhQsLJqEKHygLxdzZm3ZT0uhd5GXK0gsSR386E6_aY6DleFjSKf-UIUnDOrE4OV5SOnBZyO5TYOyBvEtELBAduzust_gENiCS414nmacbBXAXJjAAkMb4fDPa2oTuAs1Dl7BOTlahhnYhBd6auzBgasQ_AhYYlHLWmtjpSyHPPTRUDEgOgGZx6OlCffm3LkEnxOxnlANnvyPN_W_-_0yeWneEFujg8n-2p_92DvKbmVIBPFSRhnG2R9eXrmn4EpuDTPG_6j5PiqGf4P6K1svQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Jb9UwELagSBUXBGULFGokJA40ahbHdri9vvapLK04UKniYnkLFD0lT216eP-eGWehKYvENR5HtsfjmZG_-UzIa2kKn7NKxNYyHjOX5LFEMBUz0kmmDRcZFjgfn_CjU_bhrDi7VsUf0O7DlWRX04AsTXW7t3JVZ-KS713CqSpEjPACyCHwtcHb5A5ydSGob87n4z0C-D8-lMr8sd_EHQXW_t_P5mvO6SZw8sbtaXBKi_vkXh9N0lmn_gfklq-3yOZxf1_-kHxFgDsqsm7pqlmuVx1R9Zrq2tFKL5f0vP4Bq0oRYf6OQjBIu7qkXTrD14uC3H7j1hTPjR7fRRF7uH5ETheHX-ZHcf-aQmx5ItrY8UJnuZHgz4XRphReCEjGvPV4NZbaAgJBn0B0ZI2U1qYaPLvTWWFzWK5Kmvwx2aib2j8l1FsNkYzJtLUJy50GlZaZ40bA59RrHZF0WFRle6pxfPFiqULKIbnqFKHgzyooQpUReTv2WXVEG_-U3kddjZJIkh0-NBffVG9zqrJJ4gtfiYpzZnVmkOs9cVrA7Fhp04i8QU0rNGUYntV9RQJMEkmx1IyXecEhggTJ7YkkmKCdNg97RfVHwKWC1BSGjRF4RF6NzdgTYW21b66CDMRrkNXBL550W2ucUs5KrBgXERGTTTeZ87SlPv8eCMIlZIGM84jsDtvz17D-vqbP_k98h2x-PlioT-9PPj4ndzO0qTSL02KbbLQXV_4FxGqteRnM8SdicTVC
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Persistent+polypharmacy+and+fall+injury+risk%3A+the+Health%2C+Aging+and+Body+Composition+Study&rft.jtitle=BMC+geriatrics&rft.au=Xue%2C+Lingshu&rft.au=Boudreau%2C+Robert+M.&rft.au=Donohue%2C+Julie+M.&rft.au=Zgibor%2C+Janice+C.&rft.date=2021-12-15&rft.issn=1471-2318&rft.eissn=1471-2318&rft.volume=21&rft.issue=1&rft_id=info:doi/10.1186%2Fs12877-021-02695-9&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12877_021_02695_9
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2318&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2318&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2318&client=summon